Cetera Investment Advisers Humacyte, Inc. Transaction History
Cetera Investment Advisers
- $42.2 Billion
- Q2 2024
A detailed history of Cetera Investment Advisers transactions in Humacyte, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 15,711 shares of HUMA stock, worth $88,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,711
Previous 10,265
53.05%
Holding current value
$88,610
Previous $31,000
141.94%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
130Shares Held
30.8MCall Options Held
323KPut Options Held
582K-
Black Rock Inc. New York, NY7.14MShares$40.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$26.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$16.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$10.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.6MShares$9.02 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $581M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...